{
  "symbol": "MRK",
  "year": 2022,
  "period": "Y2022",
  "competition_summary": [
    {
      "competitor": "the Health Care Environment Competition",
      "mentions": 1,
      "context": "Competition and the Health Care Environment Competition The markets in which the Company conducts its business and the pharmaceutical industry in general are highly competitive and highly regulated. The Company\u2019s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, generic drug manufacturers, and animal health care companies. The Company\u2019s operations may be adversely affected by generic and biosimilar competi"
    },
    {
      "competitor": "Company",
      "mentions": 3,
      "context": "Competition and the Health Care Environment Competition The markets in which the Company conducts its business and the pharmaceutical industry in general are highly competitive and highly regulated. The Company\u2019s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, generic drug manufacturers, and animal health care companies. The Company\u2019s operations may be adversely affected by generic and biosimilar competi"
    },
    {
      "competitor": "Health Care Environment and Government",
      "mentions": 1,
      "context": "Competition and the Health Care Environment Competition The markets in which the Company conducts its business and the pharmaceutical industry in general are highly competitive and highly regulated. The Company\u2019s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, generic drug manufacturers, and animal health care companies. The Company\u2019s operations may be adversely affected by generic and biosimilar competi"
    }
  ]
}